MiniMed Group, a subsidiary of Medtronic MDT-0.12%decrease; red down pointing triangle, is looking to spin itself off as an independent company via an initial public offering. The company, which makes ...
As Medtronic begins rolling out a recently FDA-cleared diabetes management system combining its MiniMed 780G insulin pump and Abbott’s Instinct glucose sensor, the medtech giant has launched a new ...
Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean ...
Medtronic is a solid choice for dividend investors, but Intuitive Surgical is a better option for growth-oriented investors. Intuitive Surgical will continue dominating its niche even as Medtronic ...
Medtronic has launched the MiniMed 780G system in the U.S., integrated with Abbott’s Instinct sensor technology. Medtronic’s integration with Abbott was just approved by FDA in September, broadening ...
Medtronic's cardiovascular sales rise 10.8% to $3.44 bln CEO emphasizes on cardiology and neuroscience M&A CFO confirms diabetes business to go public in 2026 Nov 18 (Reuters) - Medtronic (MDT.N), ...
Medtronic Fails at Attempt to Escape Whistleblower Suit Under New Standard, Judge Rules "In sum, although the court previously rejected (and thus did not consider) the application of a but-for ...
Medical devices giant Medtronic Plc (NYSE:MDT) is scheduled to report its second-quarter fiscal year 2026 results on Tuesday, November 18. According to data from Benzinga Pro, analysts estimate ...
From left to right: Katie Adams, assistant editor at MedCity News; and Jennifer Thompson, vice president of U.S. aortic sales at Medtronic The process of commercializing a new medical device is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback